Conference Coverage

View All
Evaluating Empagliflozin’s Impact on Cardiovascular Outcomes in Patients with T2D | AHA 2024
Evaluating Empagliflozin’s Impact on Cardiovascular Outcomes in Patients with T2D | AHA 2024

November 20th 2024

Assessing SGLT-2 Inhibitors in Patients with T2D, Cardiovascular Complications | AHA 2024
Assessing SGLT-2 Inhibitors in Patients with T2D, Cardiovascular Complications | AHA 2024

November 20th 2024

Eating Problems, Diabetes Distress Associated with Worse Time-in-Range | AHA 2024
Eating Problems, Diabetes Distress Associated with Worse Time-in-Range | AHA 2024

November 19th 2024

Acoramidis Demonstrates Sustained Clinical Benefits in ATTR-CM
Acoramidis Demonstrates Sustained Clinical Benefits in ATTR-CM

November 18th 2024

Latest Multimedia

Discover the future of pharmacy!

Discover the future of pharmacy. Explore, learn and earn 1.50 CE credits. Register now!

Discover the future of pharmacy!

All News

© 2024 MJH Life Sciences

All rights reserved.